In this context, it is encouraging that CD4+ T cell-mediated anti-CSPG4 responses have been detected in both healthy individuals and melanoma patients (14, 15), and that both CD8+ T-cell clones described herein were retrieved from the peripheral blood of a melanoma patient. This evidence concerns the gene CD8A and melanoma.